Hedge funds were already waiting to see if a U.S.-fostered, home-grown artificial intelligence boom would continue as China's ...

Goldman Sachs predicts a gradual recovery for Life Sciences Tools in 2025, with bioprocessing gaining traction and improved ...

Goldman (GS) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.

Citi analyst Keith Horowitz maintained a Hold rating on Goldman Sachs Group (GS – Research Report) yesterday and set a price target of ...

While some companies steer away from diversity, equity, and inclusion (DEI) policies, others are sticking with their previous ...

Goldman Sachs Group Inc. (NYSE:GS), a leading global investment banking, securities, and investment management firm with a ...

Chinese artificial intelligence company DeepSeek is threatening to bring to an end the Wall Street artificial ...

We recently published a list of 8 Unstoppable Dividend Stocks to Invest in. In this article, we are going to take a look at ...

Goldman Sachs expects a gradual recovery in end-market growth throughout the year as the Tools and the contract research organizations (CROs) enter 2025 after underperforming in 2024.

Wall Street banks Goldman Sachs and JPMorgan Chase became the latest ... The activist groups – including the National Center for Public Policy Research, the National Legal and Policy Center ...

The Fed will likely pause its rate cuts this week. After that, uncertainty over Trump's tariff, immigration plans make ...

Not surprisingly, the parallel processing architecture that makes GPUs excel at training AI requires an immense amount of ...